These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25623492)

  • 1. Polyethylene imine-6-phosphogluconic acid nanoparticles--a novel zeta potential changing system.
    Bonengel S; Prüfert F; Perera G; Schauer J; Bernkop-Schnürch A
    Int J Pharm; 2015 Apr; 483(1-2):19-25. PubMed ID: 25623492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zeta potential changing phosphorylated nanocomplexes for pDNA delivery.
    Bonengel S; Prüfert F; Jelkmann M; Bernkop-Schnürch A
    Int J Pharm; 2016 May; 504(1-2):117-24. PubMed ID: 26453789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier.
    Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A
    Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency.
    Suchaoin W; Mahmood A; Netsomboon K; Bernkop-Schnürch A
    Nanomedicine (Lond); 2017 May; 12(9):963-975. PubMed ID: 28440703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of phosphorylated nanoparticles as zeta potential inverting systems.
    Perera G; Zipser M; Bonengel S; Salvenmoser W; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):250-6. PubMed ID: 25638505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-emulsifying drug delivery systems changing their zeta potential via a flip-flop mechanism.
    Salimi E; Le-Vinh B; Zahir-Jouzdani F; Matuszczak B; Ghaee A; Bernkop-Schnürch A
    Int J Pharm; 2018 Oct; 550(1-2):200-206. PubMed ID: 30149127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
    Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preactivated thiolated nanoparticles: A novel mucoadhesive dosage form.
    Menzel C; Bonengel S; Pereira de Sousa I; Laffleur F; Prüfert F; Bernkop-Schnürch A
    Int J Pharm; 2016 Jan; 497(1-2):123-8. PubMed ID: 26631639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zeta potential changing nanoemulsions: Impact of PEG-corona on phosphate cleavage.
    Zaichik S; Steinbring C; Jelkmann M; Bernkop-Schnürch A
    Int J Pharm; 2020 May; 581():119299. PubMed ID: 32251695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zeta potential changing self-emulsifying drug delivery systems containing phosphorylated polysaccharides.
    Griesser J; Burtscher S; Köllner S; Nardin I; Prüfert F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2017 Oct; 119():264-270. PubMed ID: 28684278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zeta potential changing self-emulsifying drug delivery systems: A promising strategy to sequentially overcome mucus and epithelial barrier.
    Nazir I; Fürst A; Lupo N; Hupfauf A; Gust R; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2019 Nov; 144():40-49. PubMed ID: 31505225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ζ potential changing nanoparticles as cystic fibrosis transmembrane conductance regulator gene delivery system: an in vitro evaluation.
    Prüfert F; Bonengel S; Köllner S; Griesser J; Wilcox MD; Chater PI; Pearson JP; Bernkop-Schnürch A
    Nanomedicine (Lond); 2017 Nov; 12(22):2713-2724. PubMed ID: 28960133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface phosphorylation of nanoparticles by hexokinase: A powerful tool for cellular uptake improvement.
    Nazir I; Leichner C; Le-Vinh B; Bernkop-Schnürch A
    J Colloid Interface Sci; 2018 Apr; 516():384-391. PubMed ID: 29408127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of nanostructured lipid carriers and solid lipid nanoparticles for enhanced cellular uptake.
    Veider F; Akkuş-Dağdeviren ZB; Knoll P; Bernkop-Schnürch A
    Int J Pharm; 2022 Aug; 624():122014. PubMed ID: 35850184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide Antibiotic-Polyphosphate Nanoparticles: A Promising Strategy to Overcome the Enzymatic and Mucus Barrier of the Intestine.
    Saleh A; Akkuş-Dağdeviren ZB; Haddadzadegan S; Wibel R; Bernkop-Schnürch A
    Biomacromolecules; 2023 Jun; 24(6):2587-2595. PubMed ID: 37224061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charge changing phosphorylated polymers: Proof of in situ mucoadhesive properties.
    Bonengel S; Jelkmann M; Oh S; Mahmood A; Ijaz M; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2016 Aug; 105():203-8. PubMed ID: 27320696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and Evaluation of Charge Reversal Solid Lipid Nanoparticles.
    Federer C; Spleis HV; Summonte S; Friedl JD; Wibel R; Bernkop-Schnürch A
    J Pharm Sci; 2022 Aug; 111(8):2270-2279. PubMed ID: 35235841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zeta potential changing nanoemulsions based on a simple zwitterion.
    Sharifi F; Jahangiri M; Nazir I; Asim MH; Ebrahimnejad P; Hupfauf A; Gust R; Bernkop-Schnürch A
    J Colloid Interface Sci; 2021 Mar; 585():126-137. PubMed ID: 33279695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack.
    Martien R; Loretz B; Schnürch AB
    Biopolymers; 2006 Nov; 83(4):327-36. PubMed ID: 16609969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus.
    Laffleur F; Hintzen F; Shahnaz G; Rahmat D; Leithner K; Bernkop-Schnürch A
    Nanomedicine (Lond); 2014 Mar; 9(3):387-96. PubMed ID: 23611618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.